Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML. - Stasik S; Burkhard-Meier C; Kramer M; Middeke JM; Oelschlaegel U; Sockel K; Ehninger G; Serve H; Müller-Tidow C; Baldus CD; Röllig C; Bornhäuser M; et al. (Blood advances, 2022)